Cutting OTLK, 7% Loss. Should Have Went 1/2 on Small Size

Outlook Therapeutics, Inc. (NASDAQ:OTLK)

Updated

NASDAQ:OTLK Outlook Therapeutics, Inc.

Beyond Technical Analysis

beyondta

Bad idea. Should have cut earlier

Comment:

Basically just giving back all gains from NBY

Comment:

Should of just held. Just got impatient, didn't like the position - waste of time

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.